Stock Analysis

Third Age Health Services Full Year 2024 Earnings: EPS: NZ$0.14 (vs NZ$0.044 in FY 2023)

Published
NZSE:TAH

Third Age Health Services (NZSE:TAH) Full Year 2024 Results

Key Financial Results

  • Revenue: NZ$15.2m (up 35% from FY 2023).
  • Net income: NZ$1.40m (up 219% from FY 2023).
  • Profit margin: 9.2% (up from 3.9% in FY 2023).
  • EPS: NZ$0.14 (up from NZ$0.044 in FY 2023).
NZSE:TAH Revenue and Expenses Breakdown July 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Aged Medical Care Services Incl Support Functions segment contributing a total revenue of NZ$8.28m (55% of total revenue). The most substantial expense, totaling NZ$22.1m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how TAH's revenue and expenses shape its earnings.

Third Age Health Services' share price is broadly unchanged from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 4 warning signs for Third Age Health Services (of which 2 can't be ignored!) you should know about.

Valuation is complex, but we're here to simplify it.

Discover if Third Age Health Services might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.